News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
MM-WES: Genetic Testing for Warfarin Sensitivity Linked with Reduction in Hospitalizations
March 16, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Cardiology Today -- All-cause hospital admissions were reduced by nearly one-third following early genetic testing for two genotype variations that influenced sensitivity to warfarin, results from the MM-WES study suggested.
Twitter
LinkedIn
Facebook
Email
Print